ID: ALA5268128

Max Phase: Preclinical

Molecular Formula: C88H107ClN34O17

Molecular Weight: 1912.04

Associated Items:

Representations

Canonical SMILES:  CC(=O)Nc1cc(C(=O)Nc2cc(C(=O)Nc3cc(C(=O)Nc4cn(C)c(C(=O)Nc5cn(C)c(C(=O)NCCC(=O)Nc6cn(C)c(C(=O)NCCCC(=O)Nc7cc(C(=O)Nc8cc(C(=O)Nc9cc(C(=O)NCCC(=O)Nc%10cc(C(=O)Nc%11cn(C)c(C(=O)Nc%12cc(C(=O)NCCC(=O)NCCCN(C)C)n(C)c%12)n%11)n(C)c%10)n(C)c9)n(C)c8)n(C)c7)n6)n5)n4)n(C)c3)n(C)c2)n(C)c1.Cl

Standard InChI:  InChI=1S/C88H106N34O17.ClH/c1-48(123)94-49-28-59(113(6)36-49)79(130)98-53-33-62(117(10)40-53)82(133)100-55-35-64(118(11)42-55)84(135)108-67-46-122(15)76(106-67)88(139)109-68-47-120(13)74(104-68)86(137)93-26-21-72(127)102-65-44-119(12)73(103-65)85(136)90-22-16-18-70(125)95-50-29-60(114(7)37-50)80(131)99-54-34-61(116(9)41-54)81(132)97-52-31-57(111(4)39-52)78(129)92-25-20-71(126)96-51-30-63(115(8)38-51)83(134)107-66-45-121(14)75(105-66)87(138)101-56-32-58(112(5)43-56)77(128)91-24-19-69(124)89-23-17-27-110(2)3;/h28-47H,16-27H2,1-15H3,(H,89,124)(H,90,136)(H,91,128)(H,92,129)(H,93,137)(H,94,123)(H,95,125)(H,96,126)(H,97,132)(H,98,130)(H,99,131)(H,100,133)(H,101,138)(H,102,127)(H,107,134)(H,108,135)(H,109,139);1H

Standard InChI Key:  CITZMMPSHBVHJR-UHFFFAOYSA-N

Associated Targets(Human)

dsDNA 365 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Jurkat 10389 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCC827 1172 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MDA-MB-231 73002 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MRC5 9203 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1912.04Molecular Weight (Monoisotopic): 1910.8475AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang M, Ma X, Zhou K, Mao H, Liu J, Xiong X, Zhao X, Narva S, Tanaka Y, Wu Y, Guo C, Sugiyama H, Zhang W..  (2021)  Discovery of Pyrrole-imidazole Polyamides as PD-L1 Expression Inhibitors and Their Anticancer Activity via Immune and Nonimmune Pathways.,  64  (9.0): [PMID:33949196] [10.1021/acs.jmedchem.1c00120]

Source